Form 483

Otsuka Pharmaceutical Development & Commercialization, Inc Form 483, 2010-10-27

FDA issued a Form 483 to Otsuka Pharmaceutical Development & Commercialization, Inc on 2010-10-27 with 1 public-safe observation.

483· Form 483 issued1 observation

Otsuka Pharmaceutical Development & Commercialization, Inc · Rockville, United States · Issued October 27, 2010

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Oct 2010
21 CFR 812.140(b)(2)

Sponsor device disposition records inadequate

Cited by Hector J Colon-Torres

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 812.140(b)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere